This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow P3Rs: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when P3Rs are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Isaacman, D. J.
Right arrow Articles by Harper, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Isaacman, D. J.
Right arrow Articles by Harper, M.
Related Collections
Right arrow Infectious Disease & Immunity

PEDIATRICS Vol. 106 No. 5 November 2000, pp. 977-982

Predictors of Bacteremia in Febrile Children 3 to 36 Months of Age

Daniel J. Isaacman, MD*, Justine Shults, PhD*, Toni K. Gross, MD*, Paris H. Davis, BA*, and Marvin Harper, MDDagger

From the * Division of Pediatric Emergency Medicine, Department of Pediatrics, Eastern Virginia Medical School, Children's Hospital of The King's Daughters, Norfolk, Virginia; and the Dagger  Division of Pediatric Emergency Medicine, Harvard Medical School, Children's Hospital of Boston, Boston Massachusetts.


    ABSTRACT
Top
Abstract
Methods
Results
Discussion
Conclusion
References

Purpose.  To develop an improved model for the prediction of bacteremia in young febrile children.

Methods.  A retrospective review was performed on patients 3 to 36 months of age seen in a children's hospital emergency department between December 1995 and September 1997 who had a complete blood count and blood culture ordered as part of their regular care. Exclusion criteria included current use of antibiotics or any immunodeficient state. Clinical and laboratory parameters reviewed included age, gender, race, weight, temperature, presence of focal bacterial infection, white blood cell count (WBC), polymorphonuclear cell count (PMN), band count, and absolute neutrophil count (ANC). Logistic regression analyses were used to identify factors associated with bacteremia, defined as growth of a pathogen in a blood culture. The model that was developed was then validated on a second dataset consisting of febrile patients 3 to 36 months of age collected from a second children's hospital (validation set).

Results.  There were 633 patients in the derivation set (46 bacteremic) and 9465 patients in the validation set (149 bacteremic). The mean age of patients in the derivation and validation sets were 15.8 months (95% confidence interval [CI]: 15.2-16.5) and 16.6 months (95% CI: 16.5-16.8), respectively; the mean temperatures were 39.1°C (95% CI: 39.0-39.2) and 39.8°C (95% CI: 39.7-39.8); 56% were male in the derivation set and 55% male in the validation set. Predictors of bacteremia identified by logistic regression included ANC, WBC, PMN, temperature, and gender. Receiver operator characteristic (ROC) analysis showed similar performance of ANC and WBC as predictors of bacteremia. When placed into a multivariate logistic regression model, band count was not significantly associated with bacteremia. Information regarding focal infection was available for 572 patients in the derivation set. The percentage of patients diagnosed with bacteremia with a focal bacterial infection was not significantly different from the percentage who had bacteremia without a focal bacterial infection (16/200 vs 30/372). Based on this dataset, a logistic regression formula was developed that could be used to develop a unique risk value for each patient based on temperature, gender, and ANC. When the final model was applied to the validation set, the area under the ROC curve (AUC) constructed from these data indicated that the model retained good predictive value (AUC for the derivation vs validation data = .8348 vs 0.8221, respectively).

Conclusions.  Use of the formulas derived here allows the clinician to estimate a child's risk for bacteremia based on temperature, ANC, and gender. This approach offers a useful alternative to predictions based on fever and WBC alone.bacteremia, detection, white blood cell.

Bacteremia occurs in 3% to 11% of febrile children 3 to 36 months of age.1-4 Because a percentage of children with bacteremia will go on to develop serious bacterial infection, clinicians have sought to identify clinical and laboratory variables that aid in its prediction. Although information from the history and physical examination are helpful, they do not provide a highly sensitive screen for the detection of bacteremia in children.1-3 Clinical predictors studied to date include the age and appearance of the child and the height of their fever.5-8 Laboratory predictors identified date include the white blood cell count (WBC), C-reactive protein, erythrocyte sedimentation rate, and other acute inflammatory mediators.9-19

Debate currently exists as to the optimal management strategy for the young child presenting with fever and no source. Practice guidelines that were developed to aid clinicians in the management of the febrile child have suggested the use of WBC as a discriminator between febrile patients who could be observed without prophylactic antibiotic therapy and those who merit treatment.20

The WBC differential is a routine component of the complete blood count (CBC). While 2 recent investigations have commented on the utility of the absolute neutrophil count (ANC),21,22 information derived from the WBC differential has not been incorporated into practice guideline recommendations. Furthermore, no studies have attempted to develop a prediction tool that incorporates information from all predictors (such as age, temperature, WBC, and ANC) to establish a unique risk value for each patient. Because the ascertainment of whether a febrile pediatric patient has bacteremia remains an educated guess even in the best of hands, it makes sense to use all information that might aid in this prediction.

    METHODS
Top
Abstract
Methods
Results
Discussion
Conclusion
References

A retrospective review was conducted of all children 3 to 36 months of age presenting to the Children's Hospital of The King's Daughters emergency department (ED) between December 1995 and December 1996 who had a CBC and a blood culture performed as part of their evaluation for fever. The decision to order a CBC and culture on an individual patient was made by the ED attending physician based on clinical suspicion and standard patient-specific risk factors. Patients were identified by generating a monthly query from the hospital's computerized microbiology log of all blood cultures obtained from the ED. During the second year of patient accrual (December 1996 through August 1997), the only cases added to the database were those of children who had both a blood culture and a CBC obtained and grew a pathogen from their blood culture. Two control patients (eligible patients presenting during the same period, who also had CBCs and blood cultures drawn that were negative) per bacteremic patient were also randomly selected. Patients excluded from the study included those patients on antibiotic therapy within 48 hours of presentation, or those with a known immunodeficiency state such as patients with sickle cell anemia, Down syndrome, immunoglobulin deficiency, or those currently on chronic steroid therapy. Records were reviewed on all eligible patients. Data abstracted on each patient included: age in months, presenting temperature in degrees centigrade, weight in kilograms, the presence or absence of a focal bacterial infection (including otitis, pharyngitis, urinary tract infection, or bone and joint infection), the type of differential count performed (manual vs automated), and the CBC and blood culture results. Blood cultures characterized as true pathogens included all cultures yielding Streptococcus pneumoniae, Haemophilus influenzae, Neisseria meningitidis, group A streptococcus, or Salmonella species. Growth of Staphylococcus epidermidis, Propionibacterium acnes, and diphtheroids from immunocompetent hosts with no history of cardiac disease, ventriculoperitoneal shunts, indwelling catheters, or other prosthetic devices were categorized as contaminants. The remaining organisms were categorized on a case-by-case basis, factoring in the organism recovered, the clinical course of the patient, and the clinical diagnosis. ANC was computed as the total WBC × 103 cells/mm3 multiplied by the sum of the percentage of bands and polymorphonuclear cell count (PMN) divided by 100. In cases in which an automated differential was computed, ANC was calculated as the WBC multiplied by the percentage of granulocytes divided by 100.

Statistical Methodology

Analyses were conducted to assess cut-points of individual risk factors and to develop an approach for multivariate assessment of risk for bacteremia. To develop a multivariate model for risk, univariate analyses were first conducted to identify potential risk factors for bacteremia. The 2-sample Wilcoxon rank-sum test was used to compare the median values of continuous variables between subjects with and without bacteremia. The chi 2 test was used to assess the association between gender and an outcome of bacteremia (Table 1). Logistic regression was then used to develop a multivariate model for risk based on variables with P < .05 in the univariate analyses. Final models include variables significantly associated with an outcome of bacteremia (Table 2). The presence of interaction between variables was examined by inclusion of interaction terms. The predictive power of models 1 and 2 and models based on individual predictors was compared by constructing receiver operator characteristic (ROC) curves and comparing the areas under these curves (Fig 1). The final multivariate logistic regression model based on ANC, temperature, and gender was used to develop a formula for individual level risk that uses information from all significant predictors of bacteremia (Table 3). This model was then applied to a validation dataset derived from a large single-center study aimed at determining the risk of bacteremia in children 3 to 36 months of age in the post-H influenzae type b era.22 Data fields present in both datasets included: age, WBC, PMN, band count, temperature, gender, race, and blood culture results. The predictive value of the model was assessed by applying it to the validation set and computing the AUC for the ROC curve for the validation data. The sensitivity and specificity of a number of risk values were also tabulated and compared between both datasets. An assessment of cut-points of clinical risk factors for bacteremia was then undertaken. The best cut-point for each variable was defined as the value that simultaneously maximizes sensitivity and specificity in a logistic regression model that includes response as the outcome and a covariate that takes value 1 if the variable exceeds the cutoff value and takes value zero otherwise (Table 4). The crude and adjusted odds ratios for bacteremia for those with high versus low values were then computed and compared for each of the variables; adjustment for confounding was performed in a logistic regression model that included other significant predictors for bacteremia.

                              
View this table:
[in this window]
[in a new window]
 

TABLE 1
Results of Univariate Analyses in the Derivation Sample*

                              
View this table:
[in this window]
[in a new window]
 

TABLE 2
Logistic Regression Results*


View larger version (23K):
[in this window]
[in a new window]
 
Fig. 1.   ROC curves for each significant predictor of bacteremia and the final model based on temperature, gender, and ANC are displayed. A poor test will lead to a line with a slope of 45 degrees, as each increase in sensitivity comes at a cost of an equivalent increase in the false-positive rate. A good test will yield high sensitivity and low false-positive rates and will correspond to a curve that lies left of, and above, a worse test.

                              
View this table:
[in this window]
[in a new window]
 

TABLE 3
Experimental Sample (Validation Sample)

                              
View this table:
[in this window]
[in a new window]
 

TABLE 4
Best Cut-Points

    RESULTS
Top
Abstract
Methods
Results
Discussion
Conclusion
References

Six hundred thirty-three patients met study criteria. Fifty-six percent of patients in the derivation set were male and 63% were black. The mean age of the study population was 15.8 months (95% confidence interval [CI]: 15.2-16.5) and the mean presenting temperature was 39.1°C (95% CI: 39.0-39.2). Comparative data for the validation set showed: 55% of patients were male; mean age was 16.6 months (95% CI: 16.5-16.8); mean temperature was 39.8°C (95% CI: 39.7-39.8). The mean presenting temperature in the validation set was significantly higher than that in the derivation set (P < .001).

Forty-six cultures in the derivation set yielded a pathogen. S pneumoniae was the predominant organism identified (39 cases). The other organisms identified included N meningitidis (1), Streptococcus pyogenes (1), Salmonella species (1), Escherichia coli (1), Acinetobacter baumannii (1), and Staphylococcus aureus (2). There was no difference in pathogen recovery rate from patients who had a focal infection identified on the initial examination (16/200; 8%) versus those who had no focus identified (30/372; 8%). Contaminants identified included S epidermidis (15), Alpha streptococcus (6), diphtheroids (2), S aureus (1), Staphylococcus haemolyticus (1), A baumannii (1), Micrococcus (1), Bacillus species (1), and mixed contaminants (1).

Univariate analyses identified temperature, band count, PMN, ANC, WBC, and gender as being significantly associated with an outcome of bacteremia (Table 1). Female gender was also noted to be significantly associated with the outcome of bacteremia (30/46 females with bacteremia vs 247/586 females without bacteremia; P = .002 by chi 2 testing). Multiple logistic regression identified gender, WBC, ANC, and PMN count as significant predictors of bacteremia. Because ANC values are dependent on both WBC and PMN, 2 logistic regression models were fit---one that included temperature, gender, WBC, band count, and PMN and one that included temperature, gender, band count, and ANC. All variables except band count and temperature remained significant predictors of bacteremia in the final multivariate models (Table 2). Because temperature was identified as a significant predictor in earlier studies,1-3,21,22 it was retained as a covariate in the final models. To compare the predictive power of the final models, ROC curves were constructed and the areas under the curves were compared. ROC curves were also constructed for each individual predictor (Fig 1). The final logistic regression formula for a subject's risk of bacteremia based on his or her values of temperature, gender and ANC is given by:
<UP>risk = e</UP><SUP><IT>w</IT></SUP><UP>/</UP>(<UP>1 + e</UP><SUP><IT>w</IT></SUP>)<UP>,</UP>
where w = .1673*ANC + .2006*temperature + .8434*gender (1 = female; 0 = male) - 12.454.

This model can be used to calculate an individual risk factor for each patient based on the above variables ("Appendix"). The sensitivity and specificity of a variety of treatment thresholds are displayed (Table 3). When the multivariate model based on temperature, gender, and ANC (model 1 of Table 2) was applied to the validation set, we found it to demonstrate good predictive power (area under the ROC curve: .8221). The area under the curve in both the derivation and validation set were similar (.8348 vs .8221, respectively). A variety of laboratory cut-points were found to show similar sensitivity and specificity values when applied to both datasets (Table 4).

The best cut-points for individual level clinical risk factors were then identified as those values that simultaneously maximize the sensitivity and specificity for our data. The sensitivity, specificity, and unadjusted and adjusted odds ratios for the best cutoff values for each risk factor are displayed (Table 4).

    DISCUSSION
Top
Abstract
Methods
Results
Discussion
Conclusion
References

Our data suggest that the WBC differential provides useful information to the clinician in assessing the chances that a given febrile child may have bacteremia. As current practice guidelines suggesting empiric treatment for all children 3 to 36 months of age with temperatures of >= 39°C and WBCs >= 15 000 cells/mm3 lead to the unnecessary treatment in ~85% of instances, it is important to search for screening tools that may yield improved diagnostic accuracy for the detection of bacteremia. Although the risk values derived from our equation are not highly sensitive or specific, these values offer a useful alternative to a screen based on the height of the fever and the total WBC.

Our data agree with 2 recent studies investigating similar study questions. Kuppermann et al21 analyzed the utility of an automated WBC differential for the detection of pneumococcal bacteremia in children. His data, based on 164 cases of occult pneumococal bacteremia occurring in 6579 patients, suggested that an ANC value of >= 10 000 cells/mm3 was a better discriminator of bacteremia than a WBC of >= 15 000 cells/mm3. From a large dataset derived from a computerized hospital database, Lee and Harper22 assessed the risk of pneumococcal bacteremia in febrile young children in the post-H influenzae type b era. They concluded that adopting a cut-point of a WBC of >= 18 000 cells/mm3 might lead to less unnecessary utilization of antibiotics without sacrificing significant sensitivity for the detection of disease. Both of these studies looked only at the discriminatory power of the WBC and ANC for detecting pneumococcal bacteremia and did not assess the utility of this test for detecting occult bacteremia in general.

Examination of the table of cut-point values (Table 4) suggests that subjects are at increased risk for having bacteremia if the ANC value exceeds 9.46 or if the WBC value exceeds 14.3. Exceeding the best cut-point for PMN (59) or for temperature (39.6) is not as highly predictive of bacteremia as is exceeding the cut-point for ANC or WBC. The adjusted OR for being positive for bacteremia for those in the high versus low PMN group is 1.89 for PMN and is 1.50 or 1.19 for temperature (Table 4). This suggests that having a high ANC or WBC value may be the strongest indication that a subject will develop bacteremia.

Although the ROC curve (Fig 1) corresponding to the model based on temperature, gender, and ANC as covariates is not markedly different from that based on temperature, gender, and WBC, it is important to note that even small improvements in sensitivity and specificity of the model have huge medical and economic implications. For example, when the practice guidelines developed by Baraff et al20 are applied to our dataset, they yield a sensitivity of 54% and a specificity of 86% for the detection of bacteremia. If one uses our model's cutpoint that has equivalent sensitivity to the practice guidelines, the corresponding specificity would be raised to 90% (an absolute increase in specificity of 4%). Alternatively, if we adopted a cut-point to have the same specificity (86%) as that yielded by the practice guidelines, our sensitivity would be 69%, an absolute increase in sensitivity of 15%. Translated over the thousands of febrile children evaluated yearly, these improvements in sensitivity and specificity represent a significant advance.

Little has been written regarding the incidence of bacteremia in children with focal infections. In a cohort of 1666 young children retrospectively identified who had otitis media and had a blood culture obtained, Schutzman et al23 noted a similar incidence of bacteremia (3%) to those seen in the same ED with fever and no source of infection. Although our study design does not allow for a true approximation of incidence, our data agree with that of Schutzman et al23 in that patients with focal bacterial infections who had blood cultures obtained had the same incidence of bacteremia as those with no source. Both studies may suffer from a selection bias, which may have artificially inflated the incidence of bacteremia in these groups.

One of the interesting findings noted during this study was the limited usefulness of the band count as a predictor of bacteremia, relative to WBC, PMN, and ANC. Our data agree with that of Kuppermann et al21 and Wack et al24 who also noted that band count may be more of a nonspecific indicator of stress. Band count has been shown to be elevated in patients with meningococcemia, yet the predictive utility of this result is limited in a disease of such low incidence.25

We were surprised to find that females in our derivation set were at increased risk for bacteremia. This finding is contrary to prevailing opinion, which has noted that males have a slightly increased risk for occult bacteremia. Because our distribution of pathogens mirrors that of most studies, we do not believe that our gender findings are related to the increased prevalence of urinary tract infections or other focal infection in our population. This finding remains unexplained.

Although the ROC curve does demonstrate that the model based on ANC, temperature, and gender derived from this study is a better predictor of bacteremia than that currently used by the practice guidelines, practical application of this information requires the entry of the individual patient's temperature, gender, and ANC into a scientific calculator that would then compute an individual risk for each patient based on our final regression formula (Table 3). This risk value incorporates more of the clinical information available than is currently used and can be used by clinicians to estimate the patient's probability of having bacteremia and choose a treatment strategy. The fact that the model applied equally well to the validation set supports its generalizability. Additional studies could also examine the usefulness of this model in other datasets.

It is important to note that none of the models derived have the exquisite sensitivity and specificity that clinicians demand. The management of the febrile pediatric patient will remain a clinical situation that calls for an educated guess of a patient's risk for bacteremia based on the available data at hand. Certainly if the experimental efficacy of the conjugate pneumococcal vaccine leads to a marked reduction in pneumococcal bacteremia, the management of the febrile child may change dramatically. Regardless of the treatment strategy that is chosen, close follow-up of these patients is still a sine qua non for effective management of this clinical problem.

Limitations of the study are related to the retrospective nature of the data collected, the entry of patients based on the clinician's determination of the need for CBC and blood culture rather than discreet entry criteria, and the small number of patients with the outcome of interest. It is important to note that as patient accrual in the second year was limited to bacteremic patients (with 2 controls added per bacteremic) our data cannot be used to estimate true incidence of disease. The fact that the mean temperature in the derivation set (39.2°C) was significantly lower than that in the validation set (39.8°C) reflects differences in entry criteria for the 2 study populations. Although some patients in the derivation set were entered with temperatures that were lower than the common testing threshold of 39.0°C, we might expect that the clinicians caring for these children believed a unique clinical indication for the test (such as history of higher fevers before presentation, history of rigors, or general toxicity on examination). Entry criteria into the derivation set were designed to assess the utility of the CBC as a prediction tool for occult bacteremia in a population of patients with suspected occult bacteremia derived from a pediatric ED comprised of fellowship-trained pediatric emergency physicians.

    CONCLUSION
Top
Abstract
Methods
Results
Discussion
Conclusion
References

In summary, ANC seems to be equivalent to WBC as a predictor of bacteremia in young febrile children. We suggest that utilization of the formula derived in this study may yield more accurate estimates of the risk of bacteremia than are those derived from current practice guidelines. Band count alone does not seem to be as good a predictor of bacteremia as was previously suggested.

    APPENDIX.

Application of the Formula for Calculating an Individual Patient's Risk

Patient A is a male with an ANC value of 23.0 and temperature of 40.3°C. Using model 1 (Table 2), we calculate his risk for bacteremia as:
e<SUP>w</SUP>/(1+e<SUP>w</SUP>),
where
w=.1673×23.0+.2006×40.2+.84343×0−12.454,
so that his risk is .372. As this risk value well exceeds the suggested cut-point of .07, the patient would be deemed at significant risk for bacteremia. Consultation of Table 3 shows that a test that classifies patients with a risk value that exceeds .37 as bacteremic has extremely high specificity and very low sensitivity in both the developmental and the validation datasets. This suggests that the best cutoff risk value for a test for bacteremia will be <.37. The risk value that simultaneously maximizes sensitivity and specificity in the developmental and validation datasets is .07, which is well below the risk value of this patient. This risk value is thus a useful supplement to the current practice guidelines, which would categorize this patient as a candidate for prophylactic antibiotic treatment.

Patient B is a male with an ANC value of 7.8 and temperature of 41.0. As for patient A, we calculate his risk for bacteremia as:
e<SUP>w</SUP>/(1+e<SUP>w</SUP>),
where
w=.1673×7.8+.2006×41.0+.84343×0−12.454.
This yields a risk value of .02. Because this value is well below the risk value that maximizes sensitivity and specificity in Table 3 (.07), this patient would not be treated. The closest risk value to .02 in Table 3 is .05. A test that classifies all patients with a risk value of at least .05 as bacteremic would have 38% and 42% false-positive rates in the developmental and validation datasets, which also suggests that this risk value does not indicate an outcome of bacteremia. This is in accordance with the practice guidelines, which would also categorize this patient at low risk for bacteremia.

    ACKNOWLEDGMENTS

We thank Arno Zaritsky, MD, and Ardythe Morrow, PhD, for their careful review and advice regarding the manuscript; Kimberley Kelly and Cindy Buckler for help with manuscript preparation; and Justin Klaff for help with data abstraction.

    FOOTNOTES

Received for publication Sep 29, 1998; accepted Jan 7, 2000.

This work was presented in part at the Southern Society for Pediatric Research; February 6, 1997; New Orleans, LA; and at the Pediatric Academic Societies Annual Meeting; May 5, 1997; Washington, DC.

Reprint requests to (D.J.I.) Children's Hospital of the King's Daughters, 601 Children's Ln, Norfolk, VA 23507. E-mail: disaacma{at}chkd.com

    ABBREVIATIONS

WBC, white blood cell count; CBC, complete blood count; ANC, absolute neutrophil count; ED, emergency department; PMN, polymorphonuclear cell count; ROC, receiver operator characteristic; CI, confidence interval.

    REFERENCES
Top
Abstract
Methods
Results
Discussion
Conclusion
References
  1. McGowan JE, Bratton L, Klein JO, Finland M Bacteremia in febrile children seen in a "walk-in" pediatric clinic. N Engl J Med 1973; 288:1309-1312
  2. Bass JW, Steel R, Wittler R, Antimicrobial treatment of occult bacteremia: a multicenter cooperative study. Pediatr Infect Dis J 1993; 12:466-473 [Medline]
  3. Teele D, Pelton S, Grant M Bacteremia in febrile children under 2 years of age: results of cultures of blood of 600 consecutive febrile children seen in a "walk-in" clinic. J Pediatr 1975; 87:227-230 [CrossRef][Medline]
  4. Waskerwitz S, Berkelhamer JE Outpatient bacteremia: clinical findings in children under two years with initial temperatures of 39.5°C or higher. J Pediatr 1981; 99:213-233
  5. McCarthy P, Lembo RM, Baron MA, Fink HD, Cicchetti DV Predictive value of abnormal physical examination findings in ill-appearing and well-appearing febrile children. Pediatrics 1985; 76:167-171 [Abstract/Free Full Text]
  6. Teach SJ, Fleisher GR Efficacy of an observation scale in detecting bacteremia in febrile children three to thirty-six months of age, treated as outpatients. Pediatrics 1995; 126:877-891
  7. McCarthy P, Sharpe M, Spiesel S Observation scales to identify serious illness in febrile children. Pediatrics 1982; 70:802-809 [Abstract/Free Full Text]
  8. Bass JW, Wittler R, Weisse M Social smile and occult bacteremia. Pediatr Infect Dis J 1996; 15:541 [Medline]
  9. Bennish M, Beem M, Ormisle V C-reactive protein zeta sedimentation ratio as indicators of bacteremia in pediatric patients. J Pediatr 1984; 104:729-732 [Medline]
  10. McCarthy PL, Jekel J, Dolan T Comparison of acute-phase reactants in pediatric patients with fever. Pediatrics 1978; 62:716-720 [Abstract/Free Full Text]
  11. McCarthy PL, Frank AL, Ablow RC, Masters SJ, Dolan T Value of the C-reactive protein test in the differentiation of bacterial and viral pneumonia. J Pediatr 1978; 92:454-456 [CrossRef][Medline]
  12. Stanley T, Barrett D, Salmond C Viral and bacterial infection in childhood: the value of C-reactive protein. N Z Med J 1991; 104:138-139 [Medline]
  13. Morens DM WBC differential: value in predicting bacterial diseases in children Am J Dis Child 1979; 133:25-27 [Abstract]
  14. Todd JK Childhood infections: diagnostic value of peripheral blood cell and differential cell counts. Am J Dis Child 1974; 127:810-816
  15. Jaffe DM, Fleisher GR Temperature and total white blood cell count as indicators of bacteremia. Pediatrics 1991; 87:670-674 [Abstract/Free Full Text]
  16. Mazur L, Kozinetz C Diagnostic tests for occult bacteremia: temperature response to acetaminophen versus WBC count. Am J Emerg Med 1994; 12:403-406 [CrossRef][Medline]
  17. Saladino R, Erikson M, Levy N, Bachman D, Silber G, Fleisher GR Utility of serum interleukin-6 for diagnosis of invasive bacterial disease in children. Ann Emerg Med 1992; 21:1413-1417 [CrossRef][Medline]
  18. Benitz WE, Han MY, Madan A, Ramachandra P. Serial serum C-reactive protein levels in the diagnosis of neonatal infection. Pediatrics. 1998;102(4). URL: http://www.pediatrics.org/cgi/content/full/102/4/e41
  19. Strait RT, Kelly KJ, Kurup VP Tumor necrosis factor-alpha , interleukin-1beta , and interleukin-6 levels in febrile, young children with and without occult bacteremia. Pediatrics 1999; 104:1321-1326 [Abstract/Free Full Text]
  20. Baraff LJ, Bass JW, Fleisher GR, Practice guidelines for the management of infants and children 0-36 months of age with fever without source. Pediatrics 1993; 92:1-12 [Abstract/Free Full Text]
  21. Kuppermann N, Fleisher G, Jaffe D Predictors of occult pneumococcal bacteremia in young febrile children. Ann Emerg Med 1998; 31:679-687 [CrossRef][Medline]
  22. Lee GM, Harper MB Risk of bacteremia for febrile young children in the post- Haemophilus influenzae type b era. Arch Pediatr Adolesc Med 1998; 152:624-628 [Abstract/Free Full Text]
  23. Schutzman SA, Petrycki S, Fleisher GR Bacteremia with otitis media. Pediatrics 1991; 8:48-53
  24. Wack R, Demers D, Bass JW Immature neutrophils in the peripheral blood smear of children with viral infections. Pediatr Infect Dis J 1994; 13:228-229 [Medline]
  25. Kuppermann N, Malley R, Inkelis SH, Fleisher GR. Clinical and hematologic features do not reliably identify children with unsuspected meningococcal disease. Pediatrics. 1999; 103(2). URL: http://www.pediatrics.org/cgi/content/full/103/2/e20

Pediatrics (ISSN 0031 4005). Copyright ©2000 by the American Academy of Pediatrics



This article has been cited by other articles:


Home page
J. Clin. Pathol.Home page
D H Wyllie, I C J W Bowler, and T E A Peto
Relation between lymphopenia and bacteraemia in UK adults with medical emergencies
J. Clin. Pathol., September 1, 2004; 57(9): 950 - 955.
[Abstract] [Full Text] [PDF]


Home page
CLIN PEDIATRHome page
J. R. Casey, S. M. Marsocci, M. L. Murphy, A. B. Francis, and M. E. Pichichero
White Blood Cell Count Can Aid Judicious Antibiotic Prescribing in Acute Upper Respiratory Infections in Children
Clinical Pediatrics, March 1, 2003; 42(2): 113 - 119.
[Abstract] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow P3Rs: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when P3Rs are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Isaacman, D. J.
Right arrow Articles by Harper, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Isaacman, D. J.
Right arrow Articles by Harper, M.
Related Collections
Right arrow Infectious Disease & Immunity